Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches

References

• Adnan, M., Shamsi, A., Elasbali, A. M., Siddiqui, A. J., Patel, M., Alshammari, N., Alharethi, S. H., Alhassan, H. H., Bardakci, F., & Hassan, M. I. (2022). Structure-guided approach to discover tuberosin as a potent activator of pyruvate kinase M2, targeting cancer therapy. International Journal of Molecular Sciences, 23(21), 13172.
   Web of Science ®Google Scholar
• Ahmed, A., Mam, B., & Sowdhamini, R. (2021). DEELIG: A deep learning approach to predict protein-ligand binding affinity. Bioinformatics and Biology Insights, 15, 11779322211030364. https://doi.org/10.1177/11779322211030364
   Web of Science ®Google Scholar
• Ahmed, N., Anwar, S., & Thet Htar, T. (2017). Docking based 3D-QSAR study of tricyclic guanidine analogues of batzelladine K as anti-malarial agents. frontiers in Chemistry, 5, 36. https://doi.org/10.3389/fchem.2017.00036
   PubMed Web of Science ®Google Scholar
• AlAjmi, M. F., Khan, S., Choudhury, A., Mohammad, T., Noor, S., Hussain, A., Lu, W., Eapen, M. S., Chimankar, V., Hansbro, P. M., Sohal, S. S., Elasbali, A. M., & Hassan, M. I. (2021). Impact of deleterious mutations on structure, function and stability of serum/glucocorticoid regulated kinase 1: A gene to diseases correlation. Frontiers in Molecular Biosciences, 8, 780284. https://doi.org/10.3389/fmolb.2021.780284
   PubMed Web of Science ®Google Scholar
• Ali, S., Khan, F. I., Mohammad, T., Lan, D., Hassan, M. I., & Wang, Y. (2019). Identification and evaluation of inhibitors of lipase from Malassezia restricta using virtual high-throughput screening and molecular dynamics studies. International Journal of Molecular Sciences, 20(4), 884.
   Web of Science ®Google Scholar
• Ali, S. A., Hassan, M. I., Islam, A., & Ahmad, F. (2014). A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states. Current Protein & Peptide Science, 15(5), 456–476. https://doi.org/10.2174/1389203715666140327114232
   PubMed Web of Science ®Google Scholar
• Alotaibi, B. S., Joshi, J., Hasan, M. R., Khan, M. S., Alharethi, S. H., Mohammad, T., Alhumaydhi, F. A., Elasbali, A. M., & Hassan, M. I. (2022). Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: A combined virtual screening and MD simulation approach. Journal of Biomolecular Structure and Dynamics., 1–10. https://doi.org/10.1080/07391102.2022.2111362
   Web of Science ®Google Scholar
• Altis, A., Otten, M., Nguyen, P. H., Hegger, R., & Stock, G. (2008). Construction of the free energy landscape of biomolecules via dihedral angle principal component analysis. The Journal of Chemical Physics, 128(24), 245102. https://doi.org/10.1063/1.2945165
   PubMed Web of Science ®Google Scholar
• Amarante, M. K., & Watanabe, M. A. (2009). The possible involvement of virus in breast cancer. Journal of Cancer Research and Clinical Oncology, 135(3), 329–337. https://doi.org/10.1007/s00432-008-0511-2
   PubMed Web of Science ®Google Scholar
• Ambinder, R. F. (2018). A viral protein kinase drug target for tumors? The Journal of Clinical Investigation, 128(6), 2197–2198. https://doi.org/10.1172/JCI121080
   PubMed Web of Science ®Google Scholar
• Amir, M., Mohammad, T., Prasad, K., Hasan, G. M., Kumar, V., Dohare, R., Islam, A., Ahmad, F., & Imtaiyaz Hassan, M. (2020). Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1). Journal of Biomolecular Structure & Dynamics, 38(15), 4625–4634. https://doi.org/10.1080/07391102.2019.1682052
   PubMed Web of Science ®Google Scholar
• Anjum, F., Ali, F., Mohammad, T., Shafie, A., Akhtar, O., Abdullaev, B., & Hassan, I. (2021). Discovery of natural compounds as potential inhibitors of human carbonic anhydrase II: An integrated virtual screening, docking, and molecular dynamics simulation study. Omics: A Journal of Integrative Biology, 25(8), 513–524. https://doi.org/10.1089/omi.2021.0059
   PubMed Web of Science ®Google Scholar
• Anjum, F., Mohammad, T., Almalki, A. A., Akhtar, O., Abdullaev, B., & Hassan, M. I. (2021). Phytoconstituents and medicinal plants for anticancer drug discovery: Computational identification of potent inhibitors of PIM1 kinase. Omics: A Journal of Integrative Biology, 25(9), 580–590. https://doi.org/10.1089/omi.2021.0107
   PubMed Web of Science ®Google Scholar
• Anjum, F., Sulaimani, M. N., Shafie, A., Mohammad, T., Ashraf, G. M., Bilgrami, A. L., Alhumaydhi, F. A., Alsagaby, S. A., Yadav, D. K., & Hassan, M. I. (2022). Bioactive phytoconstituents as potent inhibitors of casein kinase-2: Dual implications in cancer and COVID-19 therapeutics. RSC Advances, 12(13), 7872–7882. https://doi.org/10.1039/d1ra09339h
   PubMed Web of Science ®Google Scholar
• Anwar, S., Khan, S., Shamsi, A., Anjum, F., Shafie, A., Islam, A., Ahmad, F., & Hassan, M. I. (2021). Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. Journal of Cellular Biochemistry, 122(10), 1445–1459. https://doi.org/10.1002/jcb.30022
   PubMed Web of Science ®Google Scholar
• Anwar, S., Shamsi, A., Kar, R. K., Queen, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020). Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases. International Journal of Biological Macromolecules, 161, 596–604. https://doi.org/10.1016/j.ijbiomac.2020.06.078
   PubMed Web of Science ®Google Scholar
• Anwar, S., Shamsi, A., Shahbaaz, M., Queen, A., Khan, P., Hasan, G. M., Islam, A., Alajmi, M. F., Hussain, A., Ahmad, F., & Hassan, M. I. (2020). Rosmarinic acid exhibits anticancer effects via MARK4 inhibition. Scientific Reports, 10(1), 10300. https://doi.org/10.1038/s41598-020-65648-z
   PubMed Web of Science ®Google Scholar
• Arunkumar, R., Sharmila, G., Elumalai, P., Senthilkumar, K., Banudevi, S., Gunadharini, D. N., Benson, C. S., Daisy, P., & Arunakaran, J. (2012). Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 19(10), 912–923. https://doi.org/10.1016/j.phymed.2012.04.009
   PubMed Web of Science ®Google Scholar
• Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., & Supuran, C. T. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews. Drug Discovery, 20(3), 200–216. https://doi.org/10.1038/s41573-020-00114-z
   PubMed Web of Science ®Google Scholar
• Baell, J. B. (2016). Feeling nature’s PAINS: Natural products, natural product drugs, and pan assay interference compounds (PAINS). Journal of Natural Products, 79(3), 616–628. https://doi.org/10.1021/acs.jnatprod.5b00947
   PubMed Web of Science ®Google Scholar
• Bailet, O., Fenouille, N., Abbe, P., Robert, G., Rocchi, S., Gonthier, N., Denoyelle, C., Ticchioni, M., Ortonne, J. P., Ballotti, R., Deckert, M., & Tartare-Deckert, S. (2009). Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Research, 69(7), 2748–2756. https://doi.org/10.1158/0008-5472.CAN-08-2690
   PubMed Web of Science ®Google Scholar
• Blancato, J., Graves, A., Rashidi, B., Moroni, M., Tchobe, L., Ozdemirli, M., Kallakury, B., Makambi, K. H., Marian, C., & Mueller, S. C. (2014). SYK allelic loss and the role of Syk-regulated genes in breast cancer survival. PLoS One, 9(2), e87610. https://doi.org/10.1371/journal.pone.0087610
   PubMed Web of Science ®Google Scholar
• Bramucci, E., Paiardini, A., Bossa, F., & Pascarella, S. (2012). PyMod: Sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL. BMC Bioinformatics, 13 Suppl 4(Suppl 4), S2. https://doi.org/10.1186/1471-2105-13-S4-S2
   PubMedGoogle Scholar
• Coopman, P. J., Do, M. T., Barth, M., Bowden, E. T., Hayes, A. J., Basyuk, E., Blancato, J. K., Vezza, P. R., McLeskey, S. W., Mangeat, P. H., & Mueller, S. C. (2000). The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature, 406(6797), 742–747. https://doi.org/10.1038/35021086
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• David, C. C., & Jacobs, D. J. (2014). Principal component analysis: A method for determining the essential dynamics of proteins. Methods in Molecular Biology (Clifton, N.J.), 1084, 193–226. https://doi.org/10.1007/978-1-62703-658-0_11
   PubMedGoogle Scholar
• Frank, C., John, P. S., & Molnar, F. (2020). Screening tools for virtual assessment of cognition. Can Fam Physician, 66, 502–503.
   PubMed Web of Science ®Google Scholar
• Gao, Y. L., Wang, N., Sun, F. R., Cao, X. P., Zhang, W., & Yu, J. T. (2018). Tau in neurodegenerative disease. Annals of Translational Medicine, 6(10), 175. https://doi.org/10.21037/atm.2018.04.23
   PubMed Web of Science ®Google Scholar
• Gimeno, A., Ojeda-Montes, M. J., Tomás-Hernández, S., Cereto-Massagué, A., Beltrán-Debón, R., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2019). The light and dark sides of virtual screening: What is there to know? International Journal of Molecular Sciences, 20(6),1375.
   PubMed Web of Science ®Google Scholar
• Guex, N., & Peitsch, M. C. (1997). SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling. electrophoresis, 18(15), 2714–2723. https://doi.org/10.1002/elps.1150181505
   PubMed Web of Science ®Google Scholar
• Guleria, V., Pal, T., Sharma, B., Chauhan, S., & Jaiswal, V. (2021). Pharmacokinetic and molecular docking studies to design antimalarial compounds targeting Actin I. International Journal of Health Sciences, 15(6), 4–15.
   Google Scholar
• Hirte, M., Meese, N., Mertz, M., Fuchs, M., & Brück, T. B. (2018). Insights into the bifunctional aphidicolan-16-ß-ol synthase through rapid biomolecular modeling approaches. Frontiers in Chemistry, 6, 101. https://doi.org/10.3389/fchem.2018.00101
   PubMed Web of Science ®Google Scholar
• Huey, R., Morris, G. M., & Forli, S. (2012). Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. The Scripps Research Institute Molecular Graphics Laboratory, 10550, 92037.
   Google Scholar
• Jairajpuri, D. S., Mohammad, T., Adhikari, K., Gupta, P., Hasan, G. M., Alajmi, M. F., Rehman, M. T., Hussain, A., & Hassan, M. I. (2020). Identification of sphingosine kinase-1 inhibitors from bioactive natural products targeting cancer therapy. ACS Omega, 5(24), 14720–14729. https://doi.org/10.1021/acsomega.0c01511
   PubMed Web of Science ®Google Scholar
• Jang, C., Yadav, D. K., Subedi, L., Venkatesan, R., Venkanna, A., Afzal, S., Lee, E., Yoo, J., Ji, E., Kim, S. Y., & Kim, M. H. (2018). Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay. Scientific Reports, 8(1), 14921. https://doi.org/10.1038/s41598-018-33354-6
   PubMedGoogle Scholar
• Jiao, Q., Bi, L., Ren, Y., Song, S., Wang, Q., & Wang, Y. S. (2018). Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Molecular Cancer, 17(1), 36. https://doi.org/10.1186/s12943-018-0801-5
   PubMedGoogle Scholar
• Kalani, K., Yadav, D. K., Alam, S., Khan, F., Kashyap, M. P., Srivastava, S. K., & Pant, A. B. (2021). In-silico studies and wet-lab validation of camptothecin derivatives for anti-cancer activity against liver (HepG2) and lung (A549) cancer cell lines. Current Topics in Medicinal Chemistry, 21(10), 908–919. https://doi.org/10.2174/1568026621666210426124719
   PubMed Web of Science ®Google Scholar
• Kemmish, H., Fasnacht, M., & Yan, L. (2017). Fully automated antibody structure prediction using BIOVIA tools: Validation study. PLoS One, 12(5), e0177923. https://doi.org/10.1371/journal.pone.0177923
   PubMed Web of Science ®Google Scholar
• Kemp, M. T., Lewandowski, E. M., & Chen, Y. (2021). Low barrier hydrogen bonds in protein structure and function. Biochimica et Biophysica Acta. Proteins and Proteomics, 1869(1), 140557. https://doi.org/10.1016/j.bbapap.2020.140557
   PubMed Web of Science ®Google Scholar
• Kim, H. H., Hyun, J. S., Choi, J., Choi, K. E., Jee, J. G., & Park, S. J. (2018). Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain. Scientific Reports, 8(1), 368. https://doi.org/10.1038/s41598-017-18332-8
   PubMedGoogle Scholar
• Kostyak, J. C., Mauri, B., Dangelmaier, C., Vari, H. R., Patel, A., Wright, M., Reddy, H., Tsygankov, A. Y., & Kunapuli, S. P. (2022). Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets. The Journal of Biological Chemistry, 298(8), 102189. https://doi.org/10.1016/j.jbc.2022.102189
   PubMed Web of Science ®Google Scholar
• Krisenko, M. O., & Geahlen, R. L. (2015). Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer. Biochimica et Biophysica Acta, 1853(1), 254–263. https://doi.org/10.1016/j.bbamcr.2014.10.022
   PubMed Web of Science ®Google Scholar
• Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: Prediction of activity spectra for biologically active substances. Bioinformatics (Oxford, England), 16(8), 747–748. https://doi.org/10.1093/bioinformatics/16.8.747
   PubMed Web of Science ®Google Scholar
• Layton, T., Stalens, C., Gunderson, F., Goodison, S., & Silletti, S. (2009). Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. The American Journal of Pathology, 175(6), 2625–2636. https://doi.org/10.2353/ajpath.2009.090543
   PubMed Web of Science ®Google Scholar
• Liddle, J., Atkinson, F. L., Barker, M. D., Carter, P. S., Curtis, N. R., Davis, R. P., Douault, C., Dickson, M. C., Elwes, D., Garton, N. S., Gray, M., Hayhow, T. G., Hobbs, C. I., Jones, E., Leach, S., Leavens, K., Lewis, H. D., McCleary, S., Neu, M., … Weingarten, G. G. (2011). Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor. Bioorganic & Medicinal Chemistry Letters, 21(20), 6188–6194. https://doi.org/10.1016/j.bmcl.2011.07.082
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today. Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Maisuradze, G. G., Liwo, A., & Scheraga, H. A. (2009). Principal component analysis for protein folding dynamics. Journal of Molecular Biology, 385(1), 312–329. https://doi.org/10.1016/j.jmb.2008.10.018
   PubMed Web of Science ®Google Scholar
• Mohammad, T., Khan, F. I., Lobb, K. A., Islam, A., Ahmad, F., & Hassan, M. I. (2019). Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4). Journal of Biomolecular Structure & Dynamics, 37(7), 1813–1829. https://doi.org/10.1080/07391102.2018.1468282
   PubMed Web of Science ®Google Scholar
• Mohammad, T., Mathur, Y., & Hassan, M. I. (2021). InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief Bioinform, 22(4), bbaa279.
   Web of Science ®Google Scholar
• Mohammad, T., Shamsi, A., Anwar, S., Umair, M., Hussain, A., Rehman, M. T., AlAjmi, M. F., Islam, A., & Hassan, M. I. (2020). Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy. Virus Research, 288, 198102. https://doi.org/10.1016/j.virusres.2020.198102
   PubMed Web of Science ®Google Scholar
• Mohammad, T., Siddiqui, S., Shamsi, A., Alajmi, M. F., Hussain, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020). Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies. Molecules, 25(4), 823. https://doi.org/10.3390/molecules25040823
   PubMed Web of Science ®Google Scholar
• Mohanraj, K., Karthikeyan, B. S., Vivek-Ananth, R. P., Chand, R. P. B., Aparna, S. R., Mangalapandi, P., & Samal, A. (2018). IMPPAT: A curated database of Indian medicinal plants, phytochemistry and therapeutics. Scientific Reports, 8(1), 4329. https://doi.org/10.1038/s41598-018-22631-z
   PubMed Web of Science ®Google Scholar
• Naqvi, A. A. T., Mohammad, T., Hasan, G. M., & Hassan, M. I. (2018). Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Current Topics in Medicinal Chemistry, 18(20), 1755–1768. https://doi.org/10.2174/1568026618666181025114157
   PubMed Web of Science ®Google Scholar
• Ogane, S., Onda, T., Takano, N., Yajima, T., Uchiyama, T., & Shibahara, T. (2009). Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma. International Journal of Cancer, 124(11), 2651–2657. https://doi.org/10.1002/ijc.24237
   PubMed Web of Science ®Google Scholar
• Otto, T., & Sicinski, P. (2017). Cell cycle proteins as promising targets in cancer therapy. Nature Reviews. Cancer, 17(2), 93–115. https://doi.org/10.1038/nrc.2016.138
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Poornima, B., Siva, B., Venkanna, A., Shankaraiah, G., Jain, N., Yadav, D. K., Misra, S., & Babu, K. S. (2017). Novel Gomisin B analogues as potential cytotoxic agents: Design, synthesis, biological evaluation and docking studies. European Journal of Medicinal Chemistry, 139, 441–453. https://doi.org/10.1016/j.ejmech.2017.07.076
   PubMed Web of Science ®Google Scholar
• Prinos, P., Garneau, D., Lucier, J. F., Gendron, D., Couture, S., Boivin, M., Brosseau, J. P., Lapointe, E., Thibault, P., Durand, M., Tremblay, K., Gervais-Bird, J., Nwilati, H., Klinck, R., Chabot, B., Perreault, J. P., Wellinger, R. J., & Elela, S. A. (2011). Alternative splicing of SYK regulates mitosis and cell survival. Nature Structural & Molecular Biology, 18(6), 673–679. https://doi.org/10.1038/nsmb.2040
   PubMed Web of Science ®Google Scholar
• Qi, W., Keenan, H. A., Li, Q., Ishikado, A., Kannt, A., Sadowski, T., Yorek, M. A., Wu, I. H., Lockhart, S., Coppey, L. J., Pfenninger, A., Liew, C. W., Qiang, G., Burkart, A. M., Hastings, S., Pober, D., Cahill, C., Niewczas, M. A., Israelsen, W. J., … King, G. L. (2017). Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nature Medicine, 23(6), 753–762. https://doi.org/10.1038/nm.4328
   PubMed Web of Science ®Google Scholar
• Rai, R., Dutta, R. K., Singh, S., Yadav, D. K., Kumari, S., Singh, H., Gupta, R. D., & Pratap, R. (2018). Synthesis, biological evaluation and molecular docking study of 1-amino-2-aroylnaphthalenes against prostate cancer. Bioorganic & Medicinal Chemistry Letters, 28(9), 1574–1580. https://doi.org/10.1016/j.bmcl.2018.03.057
   PubMed Web of Science ®Google Scholar
• Reddy, L., Odhav, B., & Bhoola, K. D. (2003). Natural products for cancer prevention: A global perspective. Pharmacology & Therapeutics, 99(1), 1–13. https://doi.org/10.1016/s0163-7258(03)00042-1
   PubMed Web of Science ®Google Scholar
• Richmond, T. J. (1984). Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. Journal of Molecular Biology, 178(1), 63–89. https://doi.org/10.1016/0022-2836(84)90231-6
   PubMed Web of Science ®Google Scholar
• Rose, P. W., Prlić, A., Altunkaya, A., Bi, C., Bradley, A. R., Christie, C. H., Costanzo, L. D., Duarte, J. M., Dutta, S., Feng, Z., Green, R. K., Goodsell, D. S., Hudson, B., Kalro, T., Lowe, R., Peisach, E., Randle, C., Rose, A. S., Shao, C., … Burley, S. K. (2017). The RCSB protein data bank: Integrative view of protein, gene and 3D structural information. Nucleic Acids Res,.45, D271–d281.
   PubMed Web of Science ®Google Scholar
• Roskoski, R. Jr. (2022). Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update. Pharmacological Research, 175, 106037. https://doi.org/10.1016/j.phrs.2021.106037
   PubMed Web of Science ®Google Scholar
• Ross, S. H., & Cantrell, D. A. (2018). Signaling and function of interleukin-2 in T lymphocytes. Annual Review of Immunology, 36, 411–433. https://doi.org/10.1146/annurev-immunol-042617-053352
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shafie, A., Khan, S., Mohammad, T., Anjum, F., Hasan, G. M., Yadav, D. K., Hassan., & M. I., Zehra. (2021). Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations. Pharmaceutics, 13(12), 2157., https://doi.org/10.3390/pharmaceutics13122157
   PubMed Web of Science ®Google Scholar
• Sharma, V., Jaiswal, P. K., Kumar, S., Mathur, M., Swami, A. K., Yadav, D. K., & Chaudhary, S. (2018). Discovery of aporphine analogues as potential antiplatelet and antioxidant agents: Design, synthesis, structure-activity relationships, biological evaluations, and in silico molecular docking studies. ChemMedChem, 13(17), 1817–1832. https://doi.org/10.1002/cmdc.201800318
   PubMed Web of Science ®Google Scholar
• Tiwari, M. K., Coghi, P., Agrawal, P., Shyamlal, B. R. K., Jun Yang, L., Yadav, L., Peng, Y., Sharma, R., Yadav, D. K., Sahal, D., Kam Wai Wong, V., & Chaudhary, S. (2020). Design, synthesis, structure-activity relationship and docking studies of novel functionalized arylvinyl-1,2,4-trioxanes as potent antiplasmodial as well as anticancer agents. ChemMedChem,.15(13), 1216–1228. https://doi.org/10.1002/cmdc.202000045
   PubMed Web of Science ®Google Scholar
• Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J. P., & Tybulewicz, V. L. (2000). Tyrosine kinase SYK: Essential functions for immunoreceptor signalling. Immunology Today, 21(3), 148–154. https://doi.org/10.1016/s0167-5699(99)01574-1
   PubMedGoogle Scholar
• Turner, P. (2005). XMGRACE, Version 5.1. 19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton, OR 2.
   Google Scholar
• Tutumlu, G., Dogan, B., Avsar, T., Orhan, M. D., Calis, S., & Durdagi, S. (2020). Integrating ligand and target-driven based virtual screening approaches with in vitro human cell line models and time-resolved fluorescence resonance energy transfer assay to identify novel hit compounds against BCL-2. Frontiers in Chemistry, 8, 167. https://doi.org/10.3389/fchem.2020.00167
   PubMed Web of Science ®Google Scholar
• Wang, L., Aschenbrenner, D., Zeng, Z., Cao, X., Mayr, D., Mehta, M., Capitani, M., Warner, N., Pan, J., Wang, L., Li, Q., Zuo, T., Cohen-Kedar, S., Lu, J., Ardy, R. C., Mulder, D. J., Dissanayake, D., Peng, K., Huang, Z., … Muise, A. M. (2021). Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice. Nature Genetics, 53(4), 500–510. https://doi.org/10.1038/s41588-021-00803-4
   PubMed Web of Science ®Google Scholar
• Wu, P., Nielsen, T. E., & Clausen, M. H. (2016). Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. Drug Discovery Today, 21(1), 5–10. https://doi.org/10.1016/j.drudis.2015.07.008
   PubMed Web of Science ®Google Scholar
• Yadav, D. K., Kumar, S., Teli, M. K., & Kim, M. H. (2020). Ligand-based pharmacophore modeling and docking studies on vitamin D receptor inhibitors. Journal of Cellular Biochemistry, 121(7), 3570–3583. https://doi.org/10.1002/jcb.29640
   PubMed Web of Science ®Google Scholar
• Yanagi, S., Inatome, R., Takano, T., & Yamamura, H. (2001). Syk expression and novel function in a wide variety of tissues. Biochemical and Biophysical Research Communications, 288(3), 495–498. https://doi.org/10.1006/bbrc.2001.5788
   PubMed Web of Science ®Google Scholar
• Yang, C., Alam, A., Alhumaydhi, F. A., Khan, M. S., Alsagaby, S. A., Al Abdulmonem, W., Hassan, M. I., Shamsi, A., Bano, B., & Yadav, D. K. (2022). Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase Yes (YES1): Implications in anticancer therapeutics. Molecules, 27(10), 3060. https://doi.org/10.3390/molecules27103060
   PubMed Web of Science ®Google Scholar
• Yuan, Y., Mendez, R., Sahin, A., & Dai, J. L. (2001). Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Research, 61(14), 5558–5561.
   PubMed Web of Science ®Google Scholar